Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (11): 701-702.
DOI: 10.19803/j.1672-8629.2019.11.14
Previous Articles Next Articles
ZHAO Pei, MI Cuilan, GONG Kaimin, LIU Jun
Received:2019-11-27
Revised:2019-11-27
Online:2019-11-20
Published:2019-11-27
CLC Number:
ZHAO Pei, MI Cuilan, GONG Kaimin, LIU Jun. One Case of Anaphylactic Shock Induced by Thromboplastin for Injection[J]. Chinese Journal of Pharmacovigilance, 2019, 16(11): 701-702.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgywjj.com/EN/10.19803/j.1672-8629.2019.11.14
| [1] 尹梅兰. 血栓通针剂不良反应报告分析[J].临床合理用药, 2013, 10(6):80-81. [2] 陈旭,吴旭霞,赵喜荣.注射用血栓通联合抗生素引起五例不良反应分析[J].实用药物与临床, 2012, 15(2):102-104. [3] 杨崇春,高天.血栓通注射液滴注产生局部不良反应分析[J].时珍国医国药, 2002, 13(5):319-320. [4] 张蕾. 19例注射用血栓通(冻干)不良反应分析[J].医院药学, 2013, 20(9):98. [5] 高峰丽,安慧艳.7种常用治疗心脑血管疾病的中药注射剂不良反应文献分析[J].中国药物警戒, 2011, 8(5):312-314. [6] 陈瑞云,姚苗苗,李建新,等.注射用血栓通致过敏性休克1例[J].临床合理用药, 2013, 6(7):48. [7] 李友勋. 血栓通致过敏性休克1例[J].中国现代应用药学,2013, 6(7):48. [8] 金丛兰,方贞琴.血栓通过敏性休克1例[J].中国误诊学杂志, 2007, 7(6):1420. [9] 张建民,雷招宝.血塞通与血栓通注射剂致过敏性休克的特点与合理用药[J].中成药, 2015, 37(8):1869-1870. [10] 王陈翔,周子晔.57例血栓通注射液所致不良反应分析[J].药学实践杂志, 2009, 27(4):313-314. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
